Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
IDF struck Iran's largest petrochemical plant, second facility hit in two days, Katz confirms - 27 Moves toward a Sound and Dynamic Way of life
- 3The newest 'Project Hail Mary' trailer shows Ryan Gosling befriending an alien in Phil Lord and Chris Miller's space epic
- 4Would you ever turn to AI for companionship? 6% of Americans say they could — or already have.
- 5Delta flight bound for Atlanta makes emergency landing after engine issue
- IDF, police arrest eleven for criminal, terror-related activity over weekend
- CDC vaccine panel votes to remove universal hepatitis B birth dose recommendation
- NASA begins fueling rocket to launch astronauts on the first lunar trip in half a century
- Check out the exclusive pitch deck Valerie Health used to raise $30 million from Redpoint Ventures to automate healthcare faxes
- Germany raises prospect of military forces to secure Ukraine peace
- Chris Noth responds to backlash after seemingly shading 'Sex and the City' costar Sarah Jessica Parker: 'It is not news'
- Nigeria police charge Joshua driver with dangerous driving over fatal crash
- Shelby County deputies charged with assault, placed on leave
- The most effective method to Recuperate After a Dental Embed Strategy: A Far reaching Guide
